Gilead Sciences
GILD
#129
Rank
S$194.91 B
Marketcap
S$157.09
Share price
-1.14%
Change (1 day)
30.01%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): S$12.94 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are S$29.08 Billion. In 2024 the company made an earning of S$0.89 Billion a decrease over its 2023 earnings that were of S$8.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$12.94 B1347.69%
2024 S$0.89 B-89.94%
2023 S$8.88 B17.97%
2022 S$7.53 B-29.77%
2021 S$10.72 B395.99%
2020 S$2.16 B-67.66%
2019 S$6.68 B-33.84%
2018 S$10.10 B-42.35%
2017 S$17.53 B-20.87%
2016 S$22.15 B-21.06%
2015 S$28.06 B45.8%
2014 S$19.25 B253.01%
2013 S$5.45 B16.51%
2012 S$4.68 B-1.07%
2011 S$4.73 B-6.71%
2010 S$5.07 B11.75%
2009 S$4.53 B29.5%
2008 S$3.50 B19.11%
2007 S$2.94 B-455.74%
2006 -S$0.83 Billion-154.93%
2005 S$1.50 B76.99%
2004 S$0.85 B-266.16%
2003 -S$0.52 Billion-638.24%
2002 S$95.11 M31.5%
2001 S$72.33 M-242.15%
2000 -S$50.89 Million-40.2%
1999 -S$85.1 Million31.85%
1998 -S$64.54 Million8.73%
1997 -S$59.36 Million27.22%
1996 -S$46.66 Million
1994 -S$44.45 Million26.57%
1993 -S$35.12 Million46.49%
1992 -S$23.98 Million362.5%
1991 -S$5.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.68 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.78 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.15 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.28 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.46 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.35 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.98 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.16 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.92 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA